Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
17 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
ORIONIS BIOSCIENCES from Gent, company number BE0635962088, closed financial year 2025 with a result of € 585,117 after tax. For that financial year ORIONIS BIOSCIENCES recorded revenue of € 11.6 million and equity of € 4.9 million. Compared with financial year 2024, the result moved from € 572,619 to € 585,117. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
€ 4.9 million
▲ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 585,117
▲ 2% vs 2024
Profit after tax over the fiscal year.
€ 717,707
▼ 13% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 3.2 million.
People and assets in 2025
36.3
▲ 0.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 4.6 million
▲ 17% vs 2024
€ 128,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 21,407
▲ 71% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 466,064
▲ 33% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1.2 million
▲ 70% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | € 10,714,368 | € 11,559,383 | ▲ 8% |
| Gross margin | € 4,887,929 | € 4,650,437 | € 5,204,769 | € 5,936,826 | ▲ 14% |
| Profit after taxes | € 783,655 | € 254,609 | € 572,619 | € 585,117 | ▲ 2% |
| Equity | € 3,511,703 | € 3,766,312 | € 4,338,931 | € 4,924,048 | ▲ 13% |
| Total debts | € 3,141,113 | € 2,051,652 | € 1,354,501 | € 1,951,080 | ▲ 44% |
| Cash | € 1,053,787 | € 1,825,120 | € 822,831 | € 717,707 | ▼ 13% |
| Land & buildings | - | - | - | € 318,125 | |
| Retained profit | € 1,771,180 | € 2,025,789 | € 2,598,408 | € 3,183,525 | ▲ 23% |
| Balance sheet total | € 6,652,816 | € 5,817,964 | € 5,693,432 | € 6,875,128 | ▲ 21% |
| Employees (FTE) | 34.7 | 34.2 | 35.5 | 36.3 | ▲ 0.8 |
Key figures of ORIONIS BIOSCIENCES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ORIONIS BIOSCIENCES?
What happened at ORIONIS BIOSCIENCES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 585,117 (▲ 2% vs 2024). Source: NBB ↗
- Anthony FADELL became a director. NBB
- Bihua CHEN became a director. NBB
- Nikolai KLEY became a director. NBB
- Steven GULLANS became a director. NBB
- Griet VAN POUCKE became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 783,655 profit in 2022 to € 585,117 profit in 2025.
Best year ever: 2022, with € 783,655 profit.
On average € 163,500 of value added per employee in 2025.
Management
Behind ORIONIS BIOSCIENCES are Steven GULLANS, Nikolai KLEY, Anthony FADELL, Griet VAN POUCKE and Bihua CHEN.
Directors
According to the 2025 annual accounts
Steven GULLANS
Director
since 2019
Nikolai KLEY
Director
since 2020
Anthony FADELL
Director
since 2023
Griet VAN POUCKE
Director
since 2019
Bihua CHEN
Director
since 2021
Establishments
Establishment units
Physical locations of this company
Suzanne Tassierstraat 1
9052 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 17 companies are registered at this address.
All companies at this address →VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY
€ 52.6 million revenue · 2025
LO²CUS Gent
€ 1.7 million gross margin · 2024
S-Biomedic
€ 4.4 million gross margin · 2025
VIB BIO-INCUBATOR
€ 536,162 gross margin · 2025
272BIO
€ 104,252 gross margin · 2025
+12 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
GO-DADDY-COM-LLC - GoDaddy.com, LLC, US
DNS
GoDaddy DNS
Domain
Domain
orionisbio.com
Registered
2015-04-01
Registrar
Squarespace Domains II LLC
Expires
2028-04-01
Website info
Features
Security
Details
- Company number
- 0635.962.088
- VAT number
- BE 0635.962.088
- Registered office
- Suzanne Tassierstraat 1, 9052 Gent
- Names & denominations
- ORIONIS BIOSCIENCES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 September 2015
- Peppol
- Active · Active since 19 Jun 2025
- Contact
- orionisbio.com
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied